Adare Pharma divests Adare Biome to dsm-firmenich

The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth

MoS Health addresses TB Health Technologies workshop

Urges Innovators to produce quality products that can be deployed at scale

Ecolab expands biologics resin manufacturing facility in Pennsylvania

New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.

PharmaLytica returns to Hyderabad

With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South

Hikal posts FY23 PAT at Rs. 36 Cr

Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22

PI Industries announces twin acquisitions into Pharma API & CDMO space

Aurisco expands Oligonucleotide capacity

The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.

Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development

To enable company to be future-ready by tapping potential in CDMO space

Agilent announces digital pathology workflow solution

Open, scalable, end-to-end solution to improve diagnostic quality and efficiency